These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7876871

  • 1. Long term course of change in anti-Yo antibody content in paraneoplastic cerebellar degeneration.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Nakajima T, Yamazaki M, Miyatake T, Tsuji S.
    J Neurol Neurosurg Psychiatry; 1995 Feb; 58(2):256-7. PubMed ID: 7876871
    [No Abstract] [Full Text] [Related]

  • 2. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
    Holzmann P, Holy D, Stillhard G, Janda M, Möbr P.
    Schweiz Med Wochenschr; 1998 Jun 06; 128(23):906-8. PubMed ID: 9658519
    [Abstract] [Full Text] [Related]

  • 3. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
    Tanaka K, Tanaka M, Igarashi S, Onodera O, Miyatake T, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb 06; 97(1):101-5. PubMed ID: 7788964
    [Abstract] [Full Text] [Related]

  • 4. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Idezuka J, Tsuji S.
    Exp Neurol; 1998 Apr 06; 150(2):337-8. PubMed ID: 9527904
    [Abstract] [Full Text] [Related]

  • 5. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss.
    Tanaka M, Tanaka K, Onodera O, Tsuji S.
    Clin Neurol Neurosurg; 1995 Feb 06; 97(1):95-100. PubMed ID: 7788981
    [Abstract] [Full Text] [Related]

  • 6. HLA antigens in paraneoplastic cerebellar degeneration associated with anti-Yo antibody.
    Tanaka M, Tanaka K, Tsuji S.
    Neurodegeneration; 1994 Dec 06; 3(4):341-2. PubMed ID: 7842305
    [No Abstract] [Full Text] [Related]

  • 7. Cytotoxic T cells react with recombinant Yo protein from a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Shinozawa K, Idezuka J, Tsuji S.
    J Neurol Sci; 1998 Nov 26; 161(1):88-90. PubMed ID: 9879687
    [Abstract] [Full Text] [Related]

  • 8. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K, Tanaka M, Onodera O, Tsuji S.
    Rinsho Shinkeigaku; 1995 Jul 26; 35(7):770-4. PubMed ID: 8777801
    [Abstract] [Full Text] [Related]

  • 9. Neuronal calcium channel autoantibodies coexisting with type 1 Purkinje cell cytoplasmic autoantibodies (PCA-1 or "anti-Yo").
    Lennon VA, Kryzer TJ.
    Neurology; 1998 Jul 26; 51(1):327-9. PubMed ID: 9674845
    [No Abstract] [Full Text] [Related]

  • 10. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man.
    Felician O, Renard JL, Vega F, Créange A, Chen QM, Bequet D, Delattre JY.
    Neurology; 1995 Jun 26; 45(6):1226-7. PubMed ID: 7783900
    [No Abstract] [Full Text] [Related]

  • 11. Cytotoxic T cell activity against the peptide, AYRARALEL, from Yo protein of patients with the HLA A24 or B27 supertype and paraneoplastic cerebellar degeneration.
    Tanaka M, Tanaka K, Tsuji S, Kawata A, Kojima S, Kurokawa T, Kira J, Takiguchi M.
    J Neurol Sci; 2001 Jul 15; 188(1-2):61-5. PubMed ID: 11489286
    [Abstract] [Full Text] [Related]

  • 12. Unusual neuro-ophthalmologic findings in a patient with anti-Yo-associated cerebellar degeneration.
    Cohen AB, Zupa-Fernandez A, Dalmau J, Galetta SL.
    J Neurol Sci; 2004 Oct 15; 225(1-2):153-5. PubMed ID: 15465100
    [Abstract] [Full Text] [Related]

  • 13. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration.
    Verschuuren J, Chuang L, Rosenblum MK, Lieberman F, Pryor A, Posner JB, Dalmau J.
    Acta Neuropathol; 1996 Oct 15; 91(5):519-25. PubMed ID: 8740233
    [Abstract] [Full Text] [Related]

  • 14. Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients.
    Peterson K, Rosenblum MK, Kotanides H, Posner JB.
    Neurology; 1992 Oct 15; 42(10):1931-7. PubMed ID: 1407575
    [Abstract] [Full Text] [Related]

  • 15. Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration.
    Fathallah-Shaykh H, Wolf S, Wong E, Posner JB, Furneaux HM.
    Proc Natl Acad Sci U S A; 1991 Apr 15; 88(8):3451-4. PubMed ID: 2014264
    [Abstract] [Full Text] [Related]

  • 16. Paraneoplastic cerebellar degeneration with anti-Purkinje cell antibody associated with primary tubal cancer.
    Matsushita H, Kodama S, Aoki Y, Tanaka K, Tanaka K, Saito N.
    Gynecol Obstet Invest; 1998 Apr 15; 45(2):140-3. PubMed ID: 9517809
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Anticerebellar antibodies--anti-Hu and anti-Yo--in the diagnosis of paraneoplastic neurologic syndromes].
    Grisold W, Drlicek M, Liszka U.
    Nervenarzt; 1991 Oct 15; 62(10):609-14. PubMed ID: 1749452
    [Abstract] [Full Text] [Related]

  • 20. Autoimmune paraneoplastic cerebellar degeneration: immunohistological localization of antibody-binding sites.
    Nardelli E, Currò-Dossi B, Rizzuto N, Graus F.
    Clin Neurol Neurosurg; 1995 Feb 15; 97(1):89-94. PubMed ID: 7540522
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.